{"id":715,"date":"2013-07-29T11:12:00","date_gmt":"2013-07-29T11:12:00","guid":{"rendered":"https:\/\/palladiumcapital.com\/?page_id=715"},"modified":"2015-01-19T02:52:20","modified_gmt":"2015-01-19T02:52:20","slug":"inspiremd-inc","status":"publish","type":"page","link":"https:\/\/www.palladiumcapital.com\/client-profiles\/inspiremd-inc\/","title":{"rendered":"InspireMD Inc."},"content":{"rendered":"\n\n\n
\n\n\n\n\n\n
\"web\"<\/a><\/td>\n\"chart\"<\/a><\/td>\n\"info\"<\/a><\/td>\n\"news\"<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n
\u00a0\"InspireMD\"<\/a><\/td>\n\u00a0\"InspireMD\"<\/a><\/td>\n<\/tr>\n
\u00a0\"InspireMD\"<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.<\/p>\n

 <\/p>\n

The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD\u2019s mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: embolic showers, restenosis, and late stent thrombosis.<\/p>\n

 <\/p>\n

InspireMD intends to pursue applications of its innovative technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a0 \u00a0 \u00a0 InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.   The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD\u2019s mission is to utilize its proprietary technology to make its products the […]<\/p>\n","protected":false},"author":1,"featured_media":599,"parent":22,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/client-profile.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/715"}],"collection":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/comments?post=715"}],"version-history":[{"count":0,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/715\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/22"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media\/599"}],"wp:attachment":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media?parent=715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}